Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1; European Polymer Journal; Vol. 127

Sonraí bibleagrafaíochta
Parent link:European Polymer Journal
Vol. 127.— 2020.— [109598, 9 p.]
Údar corparáideach: Национальный исследовательский Томский политехнический университет Исследовательская школа физики высокоэнергетических процессов
Rannpháirtithe: Kibler E. V. Elina Vitaljevna, Lavrinenko A. K. Anastasiya Konstantinovna, Kolesnik I. M. Iljya Maksimovich, Stankevich K. S. Ksenia Sergeevna, Bolbasov E. N. Evgeny Nikolaevich, Kudryavtseva V. L. Valeriya Lvovna, Leonov A. A. Andrey Andreevich, Schepetkin (Shchepyotkin) I. A. Igor Aleksandrovich, Khlebnikov A. I. Andrey Ivanovich, Quinn M. T. Mark, Tverdokhlebov S. I. Sergei Ivanovich
Achoimre:Title screen
Mitogen-activated protein kinases (MAPKs), including c-Jun N-terminal kinase (JNK), play important role in the regulation of pro-inflammatory cytokine secretion and signaling cascades. Therefore, JNKs are key targets for the treatment of cytokine/JNK-driven diseases. Herein, we developed electrospray poly(lactic-co-glycolic acid) (PLGA) microparticles doped with novel JNK inhibitor 11H-indeno[1,2-b]quinoxalin-11-one oxime (IQ-1). Optimized electrospray parameters allowed us to produce IQ-1-doped microparticles with round shape, smooth and non-porous surface, and mean diameter of 0.9-1.3 μm. We have shown that IQ-1 was well integrated into the polymer matrix and had a prolonged release in two steps via non-Fickian release. The fabricated particles doped with IQ-1 exhibited anti-inflammatory effects, as indicated by inhibited neutrophil activation and cytokine secretion by human monocytic MonoMac-6 cells. Overall, our study demonstrates that PLGA microparticles doped with a novel JNK inhibitor (IQ-1) could be a promising delivery system for treatment of JNK-mediated diseases.
Режим доступа: по договору с организацией-держателем ресурса
Teanga:Béarla
Foilsithe / Cruthaithe: 2020
Ábhair:
Rochtain ar líne:https://doi.org/10.1016/j.eurpolymj.2020.109598
Formáid: Leictreonach Caibidil leabhair
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664065

MARC

LEADER 00000naa0a2200000 4500
001 664065
005 20250924124359.0
035 |a (RuTPU)RU\TPU\network\35249 
035 |a RU\TPU\network\34837 
090 |a 664065 
100 |a 20210325d2020 k||y0rusy50 ba 
101 0 |a eng 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1  |f E. V. Kibler, A. K. Lavrinenko, I. M. Kolesnik [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 67 tit.] 
330 |a Mitogen-activated protein kinases (MAPKs), including c-Jun N-terminal kinase (JNK), play important role in the regulation of pro-inflammatory cytokine secretion and signaling cascades. Therefore, JNKs are key targets for the treatment of cytokine/JNK-driven diseases. Herein, we developed electrospray poly(lactic-co-glycolic acid) (PLGA) microparticles doped with novel JNK inhibitor 11H-indeno[1,2-b]quinoxalin-11-one oxime (IQ-1). Optimized electrospray parameters allowed us to produce IQ-1-doped microparticles with round shape, smooth and non-porous surface, and mean diameter of 0.9-1.3 μm. We have shown that IQ-1 was well integrated into the polymer matrix and had a prolonged release in two steps via non-Fickian release. The fabricated particles doped with IQ-1 exhibited anti-inflammatory effects, as indicated by inhibited neutrophil activation and cytokine secretion by human monocytic MonoMac-6 cells. Overall, our study demonstrates that PLGA microparticles doped with a novel JNK inhibitor (IQ-1) could be a promising delivery system for treatment of JNK-mediated diseases. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t European Polymer Journal 
463 |t Vol. 127  |v [109598, 9 p.]  |d 2020 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a electrospray 
610 1 |a drug delivery 
610 1 |a poly(lactic-co-glycolic acid) 
610 1 |a c-Jun N-terminal kinase inhibitor 
610 1 |a электрораспыление 
701 1 |a Kibler  |b E. V.  |c specialist in the field of nuclear technologies  |c Engineer of Tomsk Polytechnic University  |f 1995-  |g Elina Vitaljevna  |3 (RuTPU)RU\TPU\pers\46672 
701 1 |a Lavrinenko  |b A. K.  |g Anastasiya Konstantinovna 
701 1 |a Kolesnik  |b I. M.  |g Iljya Maksimovich 
701 1 |a Stankevich  |b K. S.  |c Physicist  |c Engineer Tomsk Polytechnic University  |f 1992-  |g Ksenia Sergeevna  |3 (RuTPU)RU\TPU\pers\37546 
701 1 |a Bolbasov  |b E. N.  |c physicist  |c Senior Researcher at Tomsk Polytechnic University, Candidate of Technical Sciences  |f 1981-  |g Evgeny Nikolaevich  |3 (RuTPU)RU\TPU\pers\30857  |9 15103 
701 1 |a Kudryavtseva  |b V. L.  |c physicist  |c Engineer of Tomsk Polytechnic University  |f 1993-  |g Valeriya Lvovna  |3 (RuTPU)RU\TPU\pers\38564 
701 1 |a Leonov  |b A. A.  |c Specialist in the field of material science  |c Specialist in educational and methodical work of Tomsk Polytechnic University  |f 1991-  |g Andrey Andreevich  |3 (RuTPU)RU\TPU\pers\38521 
701 1 |a Schepetkin (Shchepyotkin)  |b I. A.  |c doctor-biophysicist  |c leading researcher of Tomsk Polytechnic University, candidate of medical science  |f 1962-  |g Igor Aleksandrovich  |3 (RuTPU)RU\TPU\pers\37358 
701 1 |a Khlebnikov  |b A. I.  |c Chemist  |c Professor of Tomsk Polytechnic University  |f 1963-  |g Andrey Ivanovich  |3 (RuTPU)RU\TPU\pers\33927  |9 17500 
701 1 |a Quinn  |b M. T.  |g Mark 
701 1 |a Tverdokhlebov  |b S. I.  |c physicist  |c Associate Professor of Tomsk Polytechnic University, Candidate of physical and mathematical science  |f 1961-  |g Sergei Ivanovich  |3 (RuTPU)RU\TPU\pers\30855  |9 15101 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа физики высокоэнергетических процессов  |c (2017- )  |3 (RuTPU)RU\TPU\col\23551 
801 0 |a RU  |b 63413507  |c 20210325  |g RCR 
850 |a 63413507 
856 4 |u https://doi.org/10.1016/j.eurpolymj.2020.109598 
942 |c CF